FDA warns of Botox deaths in children

Article

The Food and Drug Administration (FDA) released a warning saying that botulism toxin can be lethally dangerous.

The Food and Drug Administration (FDA) released a warning saying that botulism toxin can be lethally dangerous.

The poison is used in adulterated doses as wrinkle-removers such as Botox and Myobloc, where it paralyses muscles. The agents are also used off-label in the US, and by indication in other countries, to stop tremors in cerebral palsy patients.

But the muscle paralysis can, in rare cases, go beyond the injected muscle, affecting the crucial muscles needed to breathe and swallow. A small number of people, all children, have died after receiving botulism toxin as therapy.

Advocacy group Public Citizen started a petition two weeks ago to increase the warnings on Botox and Myobloc, saying that over 180 people had adverse reactions. It is pushing for a black-box warning on the agents, which they do not currently have.

Recent Videos
Diet, mental health, and pediatric nutrition, with Colleen Sloan, PA-C, RDN
Victor Carrion, MD
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jennifer Soung, MD reacts to FDA approval of roflumilast foam 0.3%
Supporting mental health in pediatric primary care with Victor Carrion, MD
Discussing social media and potential nutrition impacts with Colleen Sloan, PA-C, RDN
Jenna Marcovitz, MA explains how music therapy helps in pediatric care
© 2025 MJH Life Sciences

All rights reserved.